GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.940
-0.070 (-2.33%)
At close: Oct 31, 2024, 4:00 PM
2.820
-0.120 (-4.08%)
After-hours: Oct 31, 2024, 6:13 PM EDT

GT Biopharma Market Cap

GT Biopharma has a market cap or net worth of $6.57 million as of October 31, 2024. Its market cap has decreased by -32.97% in one year.

Market Cap
6.57M
Enterprise Value
-2.52M
1-Year Change
-32.97%
Ranking
Category
Stock Price
$2.94

Market Cap Chart

Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.57M, a decrease of -92.10%. That is a compound annual growth rate of -31.93%.

History

DateMarket Cap% Change
Oct 30, 20246.70M-36.79%
Dec 29, 202310.60M-63.19%
Dec 30, 202228.80M-69.13%
Dec 31, 202193.30M181.02%
Dec 31, 202033.20M503.64%
Dec 31, 20195.50M-83.13%
Dec 31, 201832.60M-60.82%
Mar 27, 201883.20M-
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Aptose Biosciences 7.16M
Ontrak 7.15M
Alzamend Neuro 6.98M
Organovo Holdings 6.95M
Forte Biosciences 6.78M
Check-Cap 6.67M
Xenetic Biosciences 6.60M
Mainz Biomed 6.52M
Market Cap Rankings